Global Newborn Screening Market to Reach US$ 1,777.7 Million by 2032, Propelled by Rising Prevalence of Congenital Conditions Among Infants

March 09, 2023 | Healthcare

According to the latest report by IMARC Group, titled “Newborn Screening Market Report by Product (Instruments, Reagents), Technology (Tandem Mass Spectrometry, Pulse Oximetry, Enzyme Based Assay, DNA Assay, Electrophoresis, and Others), Test Type (Dry Blood Spot Test, CCHD, Hearing Screen), and Region 2024-2032”, the global newborn screening market size reached US$ 1,026.6 Million in 2023. Newborn screening refers to a set of laboratory evaluations and point-of-care examinations for the early detection, diagnosis, and intervention of genetic, metabolic, blood, or hormone-related disorders that may not be immediately apparent after birth. The goal is to identify diseases that cause significant morbidity, mortality, and intellectual disability (ID) early so that treatment can begin as soon as possible before symptoms appear. The newborn screening process typically involves the collection of a small sample of blood from the baby's heel to conduct a simple blood test. In the next step, the blood is tested for a number of conditions, including metabolic disorders, endocrine disorders, and blood disorders, including phenylketonuria (PKU), cystic fibrosis, and sickle cell anemia. In the event that a newborn's screening test indicates a genetic disorder, further testing is required to be performed to confirm the diagnosis so that the baby can then receive appropriate treatment and follow-up care.

Global Newborn Screening Market Trends:

The global market is majorly driven by the rising concerns regarding children's health among parents, particularly new parents. This can be attributed to the increasing prevalence of congenital conditions among infants. In line with this, the increasing awareness regarding the importance of early detection and diagnosis for facilitating prompt medical intervention and treatment is also providing an impetus to the market. Moreover, continual advancements in medical technology and genetic testing, enabling healthcare professionals to screen for a wider range of disorders than ever before, is also creating lucrative opportunities in the market. Besides this, the augmenting adoption of newborn screening programs by various governments and healthcare organizations is also impacting the market positively. Continual product innovations, such as the introduction of next-generation sequencing and tandem mass spectrometry with enhanced accuracy and speed of screening, are further creating a positive outlook for the market. Apart from this, the growing availability of direct-to-consumer genetic testing, along with an enhanced focus on personalized medicine, is enabling tailored treatments to the specific genetic makeup of individual patients, thereby fueling the market. Some of the other factors contributing to the market include the rising medical expenditure, rapid digitization, increasing penetration of high-speed internet and online health communities, and extensive research and development (R&D) activities. On account of the aforementioned factors, the market is anticipated to reach a value of US$ 1,777.7 Million by 2032, exhibiting a CAGR of 6.1% during 2024-2032.

Market Summary:

  • Based on the product, the market has been segmented into instruments and reagents. Among these, instruments hold the largest market share.
  • On the basis of the technology, the market has been divided into tandem mass spectrometry, pulse oximetry, enzyme based assay, DNA assay, electrophoresis, and others. Among these, tandem mass spectrometry holds the largest market share.
  • Based on the test type, the market has been categorized into dry blood spot test, CCHD, and hearing screen. Among these, dry blood spot test holds the largest market share.
  • On the geographical front, the market has been segregated into North America (the United States and Canada), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others), Latin America (Brazil, Mexico and others), and Middle East and Africa. Among these, North America holds the largest market share.
  • The competitive landscape of the market has been studied in the report with the detailed profiles of the key players. Some of these players include Agilent Technologies Inc., Baebies Inc., Bio-RAD Laboratories Inc., Chromsystems Instruments & Chemicals GmbH, Danaher Corporation, Masimo Corporation, Medtronic plc, Natus Medical Incorporated, Perkinelmer Inc., RECIPE Chemicals + Instruments GmbH, Thermo Fisher Scientific Inc., Trivitron Healthcare, and Waters Corporation.

Report Coverage:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Million
Segment Coverage Product, Technology, Test Type, Region
Region Covered Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Agilent Technologies Inc., Baebies Inc., Bio-RAD Laboratories Inc., Chromsystems Instruments & Chemicals GmbH, Danaher Corporation, Masimo Corporation, Medtronic plc, Natus Medical Incorporated, Perkinelmer Inc., RECIPE Chemicals + Instruments GmbH, Thermo Fisher Scientific Inc., Trivitron Healthcare and Waters Corporation
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
30 N A
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Newborn Screening Market to Reach US$ 1,777.7 Million by 2032, Propelled by Rising Prevalence of Congenital Conditions Among Infants
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More